Many plastic surgeons advocate smoking cessation before patients undergo cosmetic surgery with extensive soft-tissue dissection. Smoking cessation rates after cosmetic surgery are unknown. The preoperative consultation may be an opportunity to promote long-term smoking cessation.
This is a retrospective, cross-sectional cohort study. All patients over an 8-year study period who smoked before their preoperative consultation; who quit 2 weeks before surgery; and who subsequently underwent rhytidectomy, abdominoplasty, or mastopexy were included. Patients were asked to complete a Web-based survey at long-term follow-up.
Eighty-five smokers were included, and 47 patients completed the survey, for a response rate of 55.3 percent. Average follow-up was 63.3 months. Five respondents were social smokers and thus excluded. Of the 42 daily smokers, 17 patients (40.5 percent) were no longer smoking cigarettes on a daily basis at long-term follow-up. Of these 17 patients, 10 (23.8 percent) had not smoked since their operation. A total of 24 patients (57.1 percent) had reduced their cigarette consumption by any amount, and 70.8 percent (17 of 24) of these patients agreed that discussing adverse surgical outcomes related to smoking influenced their ability to quit/reduce. Twenty-one of 42 patients (50.0 percent) admitted that they were not compliant with the preoperative smoking cessation instructions.
This is the first report to investigate long-term smoking cessation from a cosmetic surgery practice. The authors have shown a positive association between smoking cessation and cosmetic surgery. Requesting a period of cessation before cosmetic surgery may promote long-lasting smoking cessation.
Vancouver, British Columbia, Canada
From the Division of Plastic Surgery, Department of Surgery, University of British Columbia.
Received for publication January 28, 2017; accepted March 10, 2017.
Presented at Plastic Surgery The Meeting 2016, 95th Annual Meeting of the American Association of Plastic Surgeons, in Los Angeles, California, May 19 through 22, 2016.
Disclosure:Nicholas J. Carr is a consultant for Allergan, Mentor, and Galderma. The remaining authors have no financial interests to disclose.
A “Hot Topic Video” by Editor-in-Chief Rod J. Rohrich, M.D., accompanies this article. Go to PRSJournal.com and click on “Plastic Surgery Hot Topics” in the “Digital Media” tab to watch. On the iPad, tap on the Hot Topics icon.
Aaron C. Van Slyke, M.D., M.Sc., Division of Plastic Surgery, Burn and Trauma Unit, University of British Columbia and Vancouver General Hospital, 2nd Floor, JPP 899 West 12th Avenue, Vancouver, British Columbia V5Z 1M9, Canada, email@example.com